News Releases

Date	Title
10/15/20	MiMedx Files Definitive Proxy Materials
09/21/20	MiMedx Concludes Enrollment for Phase 2B Study of Osteoarthritis (OA) of the Knee
09/21/20	MiMedx Announces Preliminary Third Quarter 2020 Net Sales
09/17/20	MiMedx Concludes Enrollment for Phase 3 Plantar Fasciitis Trial
09/14/20	MiMedx Launches EpiCord Expandable Placental Allograft as Addition to Market Leading Portfolio
08/24/20	MiMedx to Discuss Strategic Priorities at Upcoming Virtual 2019 Annual Meeting of Shareholders
08/10/20	MiMedx Welcomes Robert B. Stein, M.D., Ph.D., to Head Revitalized R&D Efforts
08/04/20	MiMedx Files Second Quarter 2020 Form 10-Q
08/03/20	MiMedx Files Definitive Proxy Materials
07/28/20	MiMedx Adds Rohit Kashyap, Ph.D., to Leadership Team as Executive Vice President and Chief Commercial Officer